Annual Cost Of Goods Sold
$8.27 B
-$4.12 B-33.27%
31 December 2023
Summary:
AstraZeneca annual cost of goods sold is currently $8.27 billion, with the most recent change of -$4.12 billion (-33.27%) on 31 December 2023. During the last 3 years, it has risen by +$2.97 billion (+56.03%). AZN annual cost of goods sold is now -33.52% below its all-time high of $12.44 billion, reached on 31 December 2021.AZN Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$3.08 B
+$898.00 M+41.14%
30 September 2024
Summary:
AstraZeneca quarterly cost of goods sold is currently $3.08 billion, with the most recent change of +$898.00 million (+41.14%) on 30 September 2024. Over the past year, it has increased by +$986.00 million (+47.06%). AZN quarterly cost of goods sold is now -33.38% below its all-time high of $4.63 billion, reached on 31 December 2021.AZN Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$9.79 B
+$986.00 M+11.20%
30 September 2024
Summary:
AstraZeneca TTM cost of goods sold is currently $9.79 billion, with the most recent change of +$986.00 million (+11.20%) on 30 September 2024. Over the past year, it has increased by +$930.00 million (+10.50%). AZN TTM cost of goods sold is now -34.26% below its all-time high of $14.89 billion, reached on 30 June 2022.AZN TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.3% | +47.1% | +10.5% |
| 3 y3 years | +56.0% | -18.0% | +4.8% |
| 5 y5 years | +67.5% | +128.1% | +89.0% |
AZN Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -33.5% | +56.0% | -33.4% | +61.7% | -34.3% | +18.4% |
| 5 y | 5 years | -33.5% | +68.0% | -33.4% | +213.1% | -34.3% | +98.9% |
| alltime | all time | -33.5% | +307.1% | -33.4% | +833.6% | -34.3% | +1086.0% |
AstraZeneca Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.08 B(+41.1%) | $9.79 B(+11.2%) |
| June 2024 | - | $2.18 B(-1.6%) | $8.80 B(+2.6%) |
| Mar 2024 | - | $2.22 B(-3.9%) | $8.58 B(+3.8%) |
| Dec 2023 | $8.27 B(-33.3%) | $2.31 B(+10.2%) | $8.27 B(-6.7%) |
| Sept 2023 | - | $2.10 B(+6.9%) | $8.86 B(-9.1%) |
| June 2023 | - | $1.96 B(+2.9%) | $9.75 B(-9.6%) |
| Mar 2023 | - | $1.91 B(-34.3%) | $10.79 B(-13.0%) |
| Dec 2022 | $12.39 B(-0.4%) | $2.90 B(-2.7%) | $12.39 B(-12.2%) |
| Sept 2022 | - | $2.98 B(-0.5%) | $14.12 B(-5.2%) |
| June 2022 | - | $3.00 B(-14.6%) | $14.89 B(+5.7%) |
| Mar 2022 | - | $3.51 B(-24.1%) | $14.08 B(+13.2%) |
| Dec 2021 | $12.44 B(+134.7%) | $4.63 B(+23.1%) | $12.44 B(+33.2%) |
| Sept 2021 | - | $3.76 B(+71.5%) | $9.34 B(+34.3%) |
| June 2021 | - | $2.19 B(+17.5%) | $6.95 B(+21.0%) |
| Mar 2021 | - | $1.86 B(+22.2%) | $5.74 B(+8.4%) |
| Dec 2020 | $5.30 B(+7.7%) | $1.52 B(+11.3%) | $5.30 B(+2.9%) |
| Sept 2020 | - | $1.37 B(+39.2%) | $5.15 B(+0.4%) |
| June 2020 | - | $984.00 M(-30.7%) | $5.13 B(-1.5%) |
| Mar 2020 | - | $1.42 B(+3.0%) | $5.21 B(+5.9%) |
| Dec 2019 | $4.92 B(-0.3%) | $1.38 B(+2.0%) | $4.92 B(-5.0%) |
| Sept 2019 | - | $1.35 B(+27.1%) | $5.18 B(+4.0%) |
| June 2019 | - | $1.06 B(-5.8%) | $4.98 B(+1.0%) |
| Mar 2019 | - | $1.13 B(-31.0%) | $4.93 B(-0.1%) |
| Dec 2018 | $4.94 B(+14.3%) | $1.64 B(+42.0%) | $4.94 B(+9.1%) |
| Sept 2018 | - | $1.15 B(+13.9%) | $4.52 B(-2.1%) |
| June 2018 | - | $1.01 B(-10.8%) | $4.62 B(+1.4%) |
| Mar 2018 | - | $1.13 B(-7.4%) | $4.56 B(+5.6%) |
| Dec 2017 | $4.32 B(+4.7%) | $1.23 B(-1.9%) | $4.32 B(+1.5%) |
| Sept 2017 | - | $1.25 B(+31.5%) | $4.25 B(+8.9%) |
| June 2017 | - | $950.00 M(+6.3%) | $3.90 B(-2.8%) |
| Mar 2017 | - | $894.00 M(-22.9%) | $4.02 B(-2.7%) |
| Dec 2016 | $4.13 B(-11.2%) | $1.16 B(+28.9%) | $4.13 B(-2.6%) |
| Sept 2016 | - | $900.00 M(-15.3%) | $4.24 B(-3.2%) |
| June 2016 | - | $1.06 B(+5.8%) | $4.38 B(-0.1%) |
| Mar 2016 | - | $1.00 B(-20.9%) | $4.38 B(-5.7%) |
| Dec 2015 | $4.65 B(-20.5%) | $1.27 B(+21.9%) | $4.65 B(-7.9%) |
| Sept 2015 | - | $1.04 B(-2.4%) | $5.04 B(-6.9%) |
| June 2015 | - | $1.07 B(-15.9%) | $5.42 B(-4.2%) |
| Mar 2015 | - | $1.27 B(-23.9%) | $5.66 B(-3.1%) |
| Dec 2014 | $5.84 B(+11.0%) | $1.67 B(+17.8%) | $5.84 B(+4.0%) |
| Sept 2014 | - | $1.42 B(+8.3%) | $5.62 B(+3.3%) |
| June 2014 | - | $1.31 B(-10.0%) | $5.44 B(-0.2%) |
| Mar 2014 | - | $1.45 B(+0.9%) | $5.45 B(+3.6%) |
| Dec 2013 | $5.26 B(-2.4%) | $1.44 B(+16.3%) | $5.26 B(+0.8%) |
| Sept 2013 | - | $1.24 B(-6.0%) | $5.22 B(-0.7%) |
| June 2013 | - | $1.32 B(+4.0%) | $5.25 B(-0.5%) |
| Mar 2013 | - | $1.27 B(-9.4%) | $5.28 B(-2.0%) |
| Dec 2012 | $5.39 B(-10.5%) | $1.40 B(+9.7%) | $5.39 B(-3.8%) |
| Sept 2012 | - | $1.27 B(-5.3%) | $5.61 B(-5.4%) |
| June 2012 | - | $1.35 B(-2.1%) | $5.93 B(-2.2%) |
| Mar 2012 | - | $1.38 B(-14.7%) | $6.06 B(+0.6%) |
| Dec 2011 | $6.03 B | $1.61 B(+1.2%) | $6.03 B(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $1.59 B(+7.5%) | $6.17 B(+1.1%) |
| June 2011 | - | $1.48 B(+10.7%) | $6.10 B(+0.5%) |
| Mar 2011 | - | $1.34 B(-23.9%) | $6.07 B(-4.9%) |
| Dec 2010 | $6.39 B(+10.6%) | $1.76 B(+15.4%) | $6.39 B(+1.5%) |
| Sept 2010 | - | $1.52 B(+5.0%) | $6.29 B(+4.3%) |
| June 2010 | - | $1.45 B(-12.2%) | $6.03 B(-0.2%) |
| Mar 2010 | - | $1.65 B(-0.7%) | $6.05 B(+4.7%) |
| Dec 2009 | $5.78 B(-12.5%) | $1.67 B(+31.8%) | $5.78 B(-7.2%) |
| Sept 2009 | - | $1.26 B(-13.7%) | $6.22 B(-4.9%) |
| June 2009 | - | $1.46 B(+5.9%) | $6.54 B(+0.5%) |
| Mar 2009 | - | $1.38 B(-34.5%) | $6.51 B(-1.3%) |
| Dec 2008 | $6.60 B(+2.8%) | $2.11 B(+33.2%) | $6.60 B(-0.4%) |
| Sept 2008 | - | $1.58 B(+10.8%) | $6.63 B(+2.8%) |
| June 2008 | - | $1.43 B(-2.7%) | $6.45 B(-0.6%) |
| Mar 2008 | - | $1.47 B(-31.3%) | $6.49 B(+1.0%) |
| Dec 2007 | $6.42 B(+15.5%) | $2.14 B(+52.4%) | $6.42 B(+9.6%) |
| Sept 2007 | - | $1.41 B(-4.4%) | $5.86 B(+1.1%) |
| June 2007 | - | $1.47 B(+4.6%) | $5.79 B(+2.3%) |
| Mar 2007 | - | $1.40 B(-11.0%) | $5.66 B(+1.8%) |
| Dec 2006 | $5.56 B(+3.8%) | $1.58 B(+17.8%) | $5.56 B(+3.5%) |
| Sept 2006 | - | $1.34 B(+0.1%) | $5.37 B(+1.8%) |
| June 2006 | - | $1.34 B(+2.5%) | $5.28 B(+0.5%) |
| Mar 2006 | - | $1.30 B(-6.0%) | $5.25 B(-2.0%) |
| Dec 2005 | $5.36 B(+3.1%) | $1.39 B(+11.5%) | $5.36 B(-2.0%) |
| Sept 2005 | - | $1.25 B(-5.2%) | $5.47 B(-0.7%) |
| June 2005 | - | $1.31 B(-6.9%) | $5.51 B(+1.1%) |
| Mar 2005 | - | $1.41 B(-5.9%) | $5.45 B(+4.9%) |
| Dec 2004 | $5.19 B(+16.4%) | $1.50 B(+16.5%) | $5.19 B(+9.4%) |
| Sept 2004 | - | $1.29 B(+2.8%) | $4.75 B(+2.5%) |
| June 2004 | - | $1.25 B(+8.0%) | $4.63 B(+3.2%) |
| Mar 2004 | - | $1.16 B(+10.2%) | $4.48 B(+0.5%) |
| Dec 2003 | $4.46 B(-1.3%) | $1.05 B(-10.1%) | $4.46 B(+0.1%) |
| Sept 2003 | - | $1.17 B(+5.6%) | $4.46 B(-3.2%) |
| June 2003 | - | $1.11 B(-2.7%) | $4.61 B(+1.0%) |
| Mar 2003 | - | $1.14 B(+8.5%) | $4.56 B(+0.9%) |
| Dec 2002 | $4.52 B(+1.4%) | $1.05 B(-20.5%) | $4.52 B(-3.4%) |
| Sept 2002 | - | $1.32 B(+24.4%) | $4.68 B(+5.7%) |
| June 2002 | - | $1.06 B(-3.1%) | $4.42 B(-1.2%) |
| Mar 2002 | - | $1.09 B(-9.3%) | $4.48 B(+0.5%) |
| Dec 2001 | $4.46 B(+37.2%) | $1.21 B(+13.3%) | $4.45 B(+37.1%) |
| Sept 2001 | - | $1.06 B(-4.3%) | $3.25 B(+3.5%) |
| June 2001 | - | $1.11 B(+3.9%) | $3.14 B(+3.2%) |
| Mar 2001 | - | $1.07 B(+12.1%) | $3.04 B(+16.0%) |
| Sept 2000 | - | $955.16 M(-5.8%) | $2.62 B(-10.2%) |
| June 2000 | - | $1.01 B(-5.3%) | $2.92 B(-6.2%) |
| Mar 2000 | - | $1.07 B(-354.9%) | $3.11 B(+52.5%) |
| Dec 1999 | $3.25 B(+59.9%) | -$420.00 M(-133.5%) | $2.04 B(-17.1%) |
| Sept 1999 | - | $1.25 B(+3.8%) | $2.46 B(+103.8%) |
| June 1999 | - | $1.21 B(+46.3%) | $1.21 B(+46.3%) |
| Dec 1998 | $2.03 B | - | - |
| June 1998 | - | $825.50 M(-12.9%) | $825.50 M(-12.9%) |
| June 1995 | - | $947.90 M | $947.90 M |
FAQ
- What is AstraZeneca annual cost of goods sold?
- What is the all time high annual cost of goods sold for AstraZeneca?
- What is AstraZeneca annual cost of goods sold year-on-year change?
- What is AstraZeneca quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for AstraZeneca?
- What is AstraZeneca quarterly cost of goods sold year-on-year change?
- What is AstraZeneca TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for AstraZeneca?
- What is AstraZeneca TTM cost of goods sold year-on-year change?
What is AstraZeneca annual cost of goods sold?
The current annual cost of goods sold of AZN is $8.27 B
What is the all time high annual cost of goods sold for AstraZeneca?
AstraZeneca all-time high annual cost of goods sold is $12.44 B
What is AstraZeneca annual cost of goods sold year-on-year change?
Over the past year, AZN annual cost of goods sold has changed by -$4.12 B (-33.27%)
What is AstraZeneca quarterly cost of goods sold?
The current quarterly cost of goods sold of AZN is $3.08 B
What is the all time high quarterly cost of goods sold for AstraZeneca?
AstraZeneca all-time high quarterly cost of goods sold is $4.63 B
What is AstraZeneca quarterly cost of goods sold year-on-year change?
Over the past year, AZN quarterly cost of goods sold has changed by +$986.00 M (+47.06%)
What is AstraZeneca TTM cost of goods sold?
The current TTM cost of goods sold of AZN is $9.79 B
What is the all time high TTM cost of goods sold for AstraZeneca?
AstraZeneca all-time high TTM cost of goods sold is $14.89 B
What is AstraZeneca TTM cost of goods sold year-on-year change?
Over the past year, AZN TTM cost of goods sold has changed by +$930.00 M (+10.50%)